Pharmaceuticals
-
Psychedelic drugs for cancer-related distress?
Psychedelic drugs could be useful to help women manage the distress of living with cancer, experts say today. Read more
-
Help with hearing may limit cognitive decline
Hearing aids may significantly benefit adults who at risk for cognitive decline, according to the findings of the first randomised trial of its kind. Read more
-
Early diagnosis call following Alzheimer’s drug success
Campaigners have called for new efforts to achieve accurate early diagnosis of Alzheimer’s disease after a conference heard promising results from a new monoclonal antibody treatment. Read more
-
Malaria vaccine boost
Africa is to get 18 million doses of the new malaria vaccine over the next two years, it has been announced. Read more
-
Call to stop opioids for lower back and neck pain
Opioids should be stopped for patients who have lower back or neck pain because they provide no pain-relief benefits, according to a new Australian study. Read more
-
Some HRT ‘associated with increased dementia risk’
Taking some types of HRT is associated with an increased rate of dementia, especially Alzheimer’s disease, a large Danish observational study has reported. Read more
-
Natural pregnancy after IVF ‘not rare’
About one in five women become pregnant naturally in the first three years after successful in vitro fertilisation, according to a new study. Read more
-
Obesity treatment hope after brown fat breakthrough
New discoveries about “brown fat” could lead to treatments for obesity and related diseases such as diabetes, British researchers say. Read more
-
Nasal spray with ketamine for severe migraine
Ketamine nasal spray may be a promising treatment for chronic migraine, reducing headache intensity and improving quality of life, researchers say today. Read more
-
Pain gene insight could improve treatment
Researchers have studied people who are genetically ‘pain insensitive’, in order to identify new analgesic strategies for treating chronic pain. Read more